Jump to ContentJump to Main Navigation
European Law and New Health Technologies$
Users without a subscription are not able to see the full content.

Mark L Flear, Anne-Maree Farrell, Tamara K Hervey, and Thérèse Murphy

Print publication date: 2013

Print ISBN-13: 9780199659210

Published to Oxford Scholarship Online: May 2013

DOI: 10.1093/acprof:oso/9780199659210.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 26 September 2021

Where the Wild Things Are: Xenotechnologies and European Hybrid Regulation

Where the Wild Things Are: Xenotechnologies and European Hybrid Regulation

Chapter:
(p.343) 16 Where the Wild Things Are: Xenotechnologies and European Hybrid Regulation
Source:
European Law and New Health Technologies
Author(s):

Siân Beynon‐Jones

Nik Brown

Publisher:
Oxford University Press
DOI:10.1093/acprof:oso/9780199659210.003.0016

This chapter analyzes the regulation of xenotechnologies in Europe, focusing on the implications of this process for humans and other animals. It argues that, although processes of purification and effacement can be discerned in the work undertaken by the Council of Europe, xenotechnologies emerge as vastly more ‘hybrid’ here than they do within the EU's medicinal products legislation. In the regulatory work conducted by the Council of Europe, humans and animals are recognized as entities with entwined interests that are placed at mutual risk through the hybrid corporeality facilitated by xenotechnological innovation. Although a degree of purification does take place, resulting in the Council's positioning of humans and animals as separate entities with unequal claims to the protection of the law, the implications of xenotechnologies for animal bodies and lives are fully acknowledged.

Keywords:   European regulation, new health technologies, hybrid theory, conceptualization, medical products legislation

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .